Skip to main content
. 2017 Feb 1;8(15):24668–24678. doi: 10.18632/oncotarget.14969

Table 3. Patients characteristics in the validation cohort.

ControlN=24 UC patientsN=36 p-value
Age (years) [median (range)] 70 (34-81) 70.5 (47-91) <0.0001
Gender n, (%)
 Male 17 (70.8) 29 (80.6) 0.386
 Female 7 (29.2) 7 (19.4)
Urine cytology n, (%)
 Negative 24 (100) 20 (55.6) <0.0001
 Positive 0 (0) 16 (44.4)
Creatinine concentration of original urine (mg/dl) [median (range)] 64.6(10.8-199.1) 76.6(17.6-261.8) 0.446
UC pathological stage n, (%)
 Ta 18 (50.0)
 T1 9 (25.0)
 ≧T2 9 (25.0)
UC pathological grade n, (%)
 Low grade 9 (25.0)
 High grade 27 (75.0)
UC, urothelial carcinoma.